COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,584 Articles (22,905 medRxiv, 8,679 bioRxiv)

Most recent first Previous |  Page 1116: Articles 11151-11160  | Next

Plant-based expression of SARS-CoV-2 antigens for use in an oral vaccine
Power, M., Azad, T., Bell, J. C., MacLean, A.
10.1101/2021.12.07.471131 — Posted: 2021-12-09
Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
Redd, A., Nardin, A., Kared, H., Bloch, E. M., Abel, B., Pekosz, A., Laeyendecker, O., Fehlings, M., Quinn, T., Tobian, A. A.
10.1101/2021.12.06.471446 — Posted: 2021-12-09
A descriptive analysis of 2020 California Occupational Safety and Health Administration COVID-19-related complaints
Thomas, M. D., Matthay, E. C., Duchowny, K. A., Riley, A. R., Khela, H., Chen, Y.-H. C., Bibbins-Domingo, K., Glymour, M. M.
10.1101/2021.12.06.21262384 — Posted: 2021-12-09
Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia's surveillance system performance
Lokuge, K., D'Onise, K., Banks, E., Street, T., Jantos, S., Baptista, M., Glass, K.
10.1101/2021.12.06.21266926 — Posted: 2021-12-09
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Cele, S., Jackson, L., Khan, K., Khoury, D. S., Moyo-Gwete, T., Tegally, H., Scheepers, C., Amoako, D., Karim, F., Bernstein, M., Lustig, G., Archary, D., Smith, M., Ganga, Y., Jule, Z., Reedoy, K., San, J. E., Hwa, S.-H., Giandhari, J., Blackburn, J., Gosnell, B. I., Karim, S. A., Hanekom, W., NGS-SA, , COMMIT-KZN Team, , von Gottberg, A., Bhiman, J., Lessells, R., Moosa, M.-Y. S., Davenport, M. P., de Oliveira, T., Moore, P. P., Sigal, A.
10.1101/2021.12.08.21267417 — Posted: 2021-12-09
Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants
Blanquart, F., Hoze, N., Cowling, B. J., Debarre, F., Cauchemez, S.
10.1101/2021.12.08.21267454 — Posted: 2021-12-09
SARS-CoV-2 variants of concern are dependent on IFITM2 for efficient replication in human lung cells
Nchioua, R., Schundner, A., Kmiec, D., Prelli Bozzo, C., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Frick, M., Sparrer, K. M. J., Kirchhoff, F.
10.1101/2021.12.06.471527 — Posted: 2021-12-09
Clinical characteristics of Chilean patients with rheumatic diseases and COVID-19: data from the Covid-19 Global Rheumatology Alliance physician-reported registry
Martinez, O., Ibanez, S., Valenzuela, F.
10.1101/2021.12.07.21267429 — Posted: 2021-12-08
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
Li, D., Xu, A., Mengesha, E., Elyanow, R., Gittelman, R. M., Chapman, H., Prostko, J. C., Frias, E. C., Stewart, J. L., Pozdnyakova, V., Debbas, P., Muzukian, A., Horizon, A. A., Merin, N., Joung, S., Botwin, G. J., Sobhani, K., Figueiredo, J. C., Cheng, S., Kaplan, I. M., McGovern, D. P. B., Merchant, A., Melmed, G. Y., Braun, J.
10.1101/2021.12.08.21267444 — Posted: 2021-12-08
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US
Bender Ignacio, R. A., Shapiro, A. E., Nance, R. M., Whitney, B. M., Delaney, J. C. A., Bamford, L., Wooten, D., Karris, M. Y., Matthews, W. C., Kim, H. N., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Jacobson, J. M., Saag, M. S., Moore, R. D., Eron, J. J., Willig, A., Christopoulos, K. A., Martin, J., Hunt, P. W., Crane, H., Kitahata, M., Cachay, E., Centers for AIDS Research Network of Integrated Clinical Systems Investigators
10.1101/2021.12.07.21267296 — Posted: 2021-12-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).